Published September 30, 2022 | Version 01
Journal article Open

Measurement and Analysis of the Half-Life of Some Viable Anti-Malaria and Analgesic Drugs

  • 1. College of Science and Education, University of Mkar, Mkar Gboko Benue State, Nigeria.

Contributors

Contact person:

  • 1. College of Science and Education, University of Mkar, Mkar Gboko Benue State, Nigeria.

Description

This paper is experimental research which focuses on the determination of the pharmaceutical half-life of some analgesic and anti-malaria drugs using the volume of distribution and clearance of the pharmacokinetic processes. Some analgesic and anti-malaria drugs were collected and administered to six healthy young men. Blood and urine samples were collected from each of them after one hour from the time of administration. All the samples for each drug were separated using a Gas chromatography machine to obtain the amount of drug remaining in the blood and the amount eliminated. The obtained values for the volume of distribution (Vd) from the blood samples and clearance (Cl) from the urine samples where mathematically evaluated with the elimination rate constant k=0.693 approximated to 0.7 to give a result with little or no error. The half-life for all samples were obtained and the pharmacokinetic properties and interactions of the drugs analysed. The various half-life obtained from this research certifies and correspond to the manufacturer's published half-life for the analysed drug samples. The high volume of distribution of Tramadol hydrochloride 70l/kg-painkiller, paracetamol 65l/kg-painkiller and artesunate 50l/kg-anti-malarial shows that they are highly absorbed into the body system and are very strong medications. They do not leave the system quickly and affects the physiological state for a long period while the low volume of distribution processes of diclofenac 1.4l/kg-painkiller, arthemeter 11.5l/kg-anti-malaria and quinine 28l/kg-anti-malaria shows a low distribution rate of these drugs, and implies they are less strong medications and does not last long in the body with their relative rates of elimination; Diclofenac 0.895l/kg/hr., arthemeter 2.6l/kg/hr. and quinine 2.4l/kg/hr.

Files

93960.pdf

Files (360.5 kB)

Name Size Download all
md5:df4b2687470a14019b07229f084d735f
360.5 kB Preview Download

Additional details

References

  • World Drug Report (2007). UNODC. https://www.unodc.org/unodc/en/data-and-analysis/WDR-2007.html.
  • Hubbard R, Craddock S, Flynn P, Anderson J & Etheridge R. (1997). Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11: 261-278.
  • Sacks S, Mc Kendrick K, Sacks J & Cleland C. (2010). Modified Therapeutic Community for Co-Occurring Disorders: Single Investigator Meta-Analysis. Substance Abuse, 31: 146-161.
  • World Drug Report (2009). UNODC.
  • Ahmed T, El-Say K, Mahmoud M, Samy A & Badawi A. (2012). Miconazole Nitrate Oral Disintegrating Tablets: In Vivo Performance and Stability Study. AAPS Pharm Sci Tech., 13: 760-771.
  • Buggins, Dickinson & Taylor (2007). The effects of pharmaceutical excipients on drug disposition. Advanced Drug Delivery Reviews, 59: 1482-1503.
  • Book Review: Applied Pharmacokinetics & Pharmacodynamics: Principles of Therapeutic Drug Monitoring, 4th Edition (2005) Annals of Pharmacotherapy, 39: 2145-2146.
  • Reviewers for the Journal of Pharmacokinetics and Pharmacodynamics (2004) Journal of Pharmacokinetics and Pharmacodynamics, 31: 341-343.
  • Hawthorn M. (1994). Applied biopharmaceutics and pharmacokinetics Third Edition: L. Shargel and A. B. C. Yu, Prentice-Hall International, London, 1993. Pages: xxii + 625. £30.00. ISBN 0-8385-0239-3. Talanta 41: 833.
  • Gawai M, Surwade & Phadatare (2018). Emphasis on Controlled Drug Delivery System-A Review. Research Journal of Pharmaceutical Dosage Forms and Technology 10: 215.
  • Nikolas, C., Eleftheria, G., Hatzidakia, G., George, N., Aristidis, M. (2005). Lead toxicity update. A brief review. Medical science monitor, 11(10): RA329-386.
  • Winter M. (2009). Basic clinical pharmacokinetics Philadelphia, Pa.: Lippincott Williams & Wilkins.
  • Curry S. (1982). Applied biopharmaceutics and pharmacokinetics, Leon Shargel and Andrew B. C. Yu, Appleton-Century-Crofts, New York, 1980. Biopharmaceutics & Drug Disposition, 3: 287-289.
  • Thornton, Stephen T, and Andrew F. Rex. (2013). Modern Physics for Scientists and Engineers. Boston, MA: Cengage Learning, Print.
  • Taylor, W.J., Diers-Caviness, M.H. (2003). A Textbook of the Clinical Application of Therapeutic Drug Monitoring. Irving, TX: Abbott laboratories Ltd, Diagnostic Division.
  • Tozer, T.N., Rowland, M. (2006). Introduction to pharmacokinetics and pharmacodynamics. The Quantitative basis of drug therapy.
  • Toutain, P.L., Bousquet-Mélou A. (2004). Volumes of distribution. J Vet Pharmacological Therapy.
  • United States national library of medicine. Half-life. medical subject headings. Tree No. G01.910.405. Retrieved June 3rd 2016.